<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <!--The publisher of this article does not allow downloading of the full text in XML form.-->
  <?properties manuscript?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-journal-id">101505086</journal-id>
      <journal-id journal-id-type="pubmed-jr-id">36963</journal-id>
      <journal-id journal-id-type="nlm-ta">Sci Transl Med</journal-id>
      <journal-id journal-id-type="iso-abbrev">Sci Transl Med</journal-id>
      <journal-title-group>
        <journal-title>Science translational medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1946-6234</issn>
      <issn pub-type="epub">1946-6242</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27510903</article-id>
      <article-id pub-id-type="pmc">5351811</article-id>
      <article-id pub-id-type="doi">10.1126/scitranslmed.aaf7837</article-id>
      <article-id pub-id-type="manuscript">NIHMS848684</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Loss-of-function mutations in the RNA biogenesis factor <italic>NAF1</italic> predispose to pulmonary fibrosis&#x2013;emphysema</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Stanley</surname>
            <given-names>Susan E.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A2">2</xref>
          <xref ref-type="author-notes" rid="FN1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gable</surname>
            <given-names>Dustin L.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A2">2</xref>
          <xref ref-type="author-notes" rid="FN1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wagner</surname>
            <given-names>Christa L.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Carlile</surname>
            <given-names>Thomas M.</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hanumanthu</surname>
            <given-names>Vidya Sagar</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Podlevsky</surname>
            <given-names>Joshua D.</given-names>
          </name>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Khalil</surname>
            <given-names>Sara E.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>DeZern</surname>
            <given-names>Amy E.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A5">5</xref>
          <xref ref-type="aff" rid="A6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rojas-Duran</surname>
            <given-names>Maria F.</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Applegate</surname>
            <given-names>Carolyn D.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A6">6</xref>
          <xref ref-type="aff" rid="A7">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alder</surname>
            <given-names>Jonathan K.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Parry</surname>
            <given-names>Erin M.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gilbert</surname>
            <given-names>Wendy V.</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Armanios</surname>
            <given-names>Mary</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A6">6</xref>
          <xref ref-type="aff" rid="A7">7</xref>
          <xref ref-type="corresp" rid="cor1">&#x2020;</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.</aff>
      <aff id="A2"><label>2</label>Medical Scientist Training Program, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.</aff>
      <aff id="A3"><label>3</label>Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</aff>
      <aff id="A4"><label>4</label>Department of Chemistry and Biochemistry, Arizona State University, Tempe, AZ 85277, USA.</aff>
      <aff id="A5"><label>5</label>Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.</aff>
      <aff id="A6"><label>6</label>Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.</aff>
      <aff id="A7"><label>7</label>McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.</aff>
      <author-notes>
        <corresp id="cor1"><label>&#x2020;</label>Corresponding author. <email>marmani1@jhmi.edu</email></corresp>
        <fn id="FN1" fn-type="equal">
          <label>*</label>
          <p id="P1">These authors contributed equally to this work.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="nihms-submitted">
        <day>4</day>
        <month>2</month>
        <year>2017</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <day>10</day>
        <month>8</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>10</day>
        <month>8</month>
        <year>2017</year>
      </pub-date>
      <volume>8</volume>
      <issue>351</issue>
      <fpage>351ra107</fpage>
      <lpage>351ra107</lpage>
      <!--elocation-id from pubmed: 10.1126/scitranslmed.aaf7837-->
      <abstract id="Abs1">
        <p id="P2">Chronic obstructive pulmonary disease and pulmonary fibrosis have been hypothesized to represent premature aging phenotypes. At times, they cluster in families, but the genetic basis is not understood. We identified rare, frameshift mutations in the gene for nuclear assembly factor 1, <italic>NAF1</italic>, a box H/ACA RNA biogenesis factor, in pulmonary fibrosis&#x2013;emphysema patients. The mutations segregated with short telomere length, low telomerase RNA levels, and extrapulmonary manifestations including myelodysplastic syndrome and liver disease. A truncated NAF1 was detected in cells derived from patients, and, in cells in which the frameshift mutation was introduced by genome editing, telomerase RNA levels were reduced. The mutant NAF1 lacked a conserved carboxyl-terminal motif, which we show is required for nuclear localization. To understand the disease mechanism, we used CRISPR (clustered regularly interspaced short palindromic repeats)/Cas9 (CRISPR-associated protein-9 nuclease) to generate <italic>Naf1<sup>+/&#x2212;</sup></italic> mice and found that they had half the levels of telomerase RNA. Other box H/ACA RNA levels were also decreased, but rRNA pseudouridylation, which is guided by snoRNAs, was intact. Moreover, first-generation <italic>Naf1<sup>+/&#x2212;</sup></italic> mice showed no evidence of ribosomal pathology. Our data indicate that disease in <italic>NAF1</italic> mutation carriers is telomere-mediated; they show that NAF1 haploinsufficiency selectively disturbs telomere length homeostasis by decreasing the levels of telomerase RNA while sparing rRNA pseudouridylation.</p>
      </abstract>
      <abstract abstract-type="summary" id="Abs2">
        <title>Tidy telomeres make for healthier lungs</title>
        <p id="P3">Telomeres are the protective caps that prevent the ends of chromosomes from unraveling. People carrying mutations in the protein or RNA component of telomerase, the enzyme that makes telomeres have short telomeres and a serious and often fatal lung disease&#x2013; &#x2013;pulmonary fibrosis. Now, Stanley <italic>et al.</italic> find in several patients that other mutations, specifically those that interfere with RNA biogenesis, can also cause both short telomeres and lung disease. This work expands our understanding of how telomeres are maintained and their role in human disease.</p>
      </abstract>
    </article-meta>
  </front>
</article>
</pmc-articleset>